Carlisle Companies Incorporated (CSL)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 1,110,900 1,153,400 1,115,400 1,055,900 948,500 931,100 975,000 1,048,200 1,195,600 1,128,700 947,300 674,900 482,500 414,000 404,400 387,500 401,300 433,200 474,000 570,100
Revenue (ttm) US$ in thousands 5,003,600 5,008,200 4,934,400 5,009,700 4,805,800 5,132,900 5,667,200 5,988,200 6,591,900 6,513,300 6,034,800 5,365,700 4,810,300 4,498,400 4,309,500 4,155,900 4,245,200 4,325,400 4,479,300 4,769,900
Pretax margin 22.20% 23.03% 22.60% 21.08% 19.74% 18.14% 17.20% 17.50% 18.14% 17.33% 15.70% 12.58% 10.03% 9.20% 9.38% 9.32% 9.45% 10.02% 10.58% 11.95%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,110,900K ÷ $5,003,600K
= 22.20%

Across the period from March 31, 2020, to December 31, 2024, Carlisle Companies Incorporated displayed fluctuations in its pretax margin. Starting at 11.95% in March 2020, the pretax margin gradually decreased to its lowest point of 9.32% by March 2021. From there, the margin saw slight variations but remained relatively stable until June 2022.

Following June 2022, there was a significant increase in the pretax margin, with values rising from 15.70% in June 2022 to a peak of 23.03% by September 30, 2024. This period was characterized by consistent growth and improved profitability for the company. However, a slight dip was observed by December 31, 2024, with the margin settling at 22.20%.

Overall, the trend in pretax margin for Carlisle Companies Incorporated showcases both periods of decline and growth, indicating fluctuations in the company's operational efficiency and profitability over the analyzed period.


Peer comparison

Dec 31, 2024

Company name
Symbol
Pretax margin
Carlisle Companies Incorporated
CSL
22.20%
West Pharmaceutical Services Inc
WST
20.24%